Parim Suhe OÜ
Parim Suhe OÜ is a OÜ based in Nõo alevik, registry code 14548552, status: active. Main activity: Other human health activities n.e.c.. According to EMTA, turnover for Q3 2026 was €1 958 with employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 1 958 €above 22% of companiesindustry median 9 428 € · companies in the industry: 351
- Revenue · 2024 4 449 €above 32% of companiesindustry median 20 000 € · companies in the industry: 3 347
- Net profit margin · 2024 7.6 %above 44% of companiesindustry median 10.7 % · companies in the industry: 2 757
Taxes and turnover
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 1 958 | 17 | — | — |
| Q2 2026 | 590 | — | — | — |
| Q1 2026 | 1 287 | — | — | — |
| Q4 2025 | 1 558 | 285 | — | — |
| Q3 2025 | 3 620 | 330 | — | — |
| Q2 2025 | 2 332 | — | — | — |
| Q1 2025 | 2 313 | — | — | — |
| Q4 2024 | 2 744 | 20 | — | — |
| Q3 2024 | 575 | — | — | — |
| Q2 2024 | 502 | — | — | — |
| Q1 2024 | 661 | — | — | — |
| Q4 2023 | 620 | — | — | — |
Financials by year
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2024 | 4 449 | 338 | 0 | 14 401 | -9 473 | 0 |
| 2023 | 3 894 | -12 514 | 0 | 19 643 | -12 311 | 0 |
| 2022 | 3 731 | 202 | 0 | 202 | 202 | 0 |
| 2021 | — | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2024
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 5 May 2026 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 30 Jun 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 30 Nov 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 4 Apr 2022 | Company’s own | e-Äriregister |
| 2019 | 21 Aug 2018 – 31 Dec 2019 | 21 Oct 2020 | Company’s own | e-Äriregister |
Board
- Jaanika LaanemetsBoard member · since 23 May 2026
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Jaanika LaanemetsNatural person · 2 500 €
Beneficial owners
- Jaanika LaanemetsDirect ownership · since 23 May 2026
Founders and other persons
- Jaanika Jõeorg-KeskülaFounder · 2 500 € · 21 Aug 2018
Related companies
Activities (EMTAK)
- 8699Other human health activities n.e.c. Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50100630 / 6 23 May 2026 |
Amendment entry | In force 23 May 2026 |
||
| Ä 50100630 / 5 27 Apr 2026 |
Amendment entry | In force 27 Apr 2026 |
||
| Ä 50100630 / 4 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 50100630 / M1 4 Apr 2022 |
Warning of a fine: annual report not filed | 4 May 2022 | In force 4 Apr 2022 |
|
| Ä 50100630 / 3 16 Aug 2021 |
Amendment entry | In force 16 Aug 2021 |
||
| Ä 50100630 / 2 8 Mar 2021 |
Amendment under Commercial Code § 525 (2) | In force 8 Mar 2021 |
||
| Ä 50100630 21 Aug 2018 |
First entry | In force 21 Aug 2018 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data